Product Information
- Lanreotide Acetate
- 10-(4-Aminobutyl)-19-[(2-Amino-3-Naphthalen-2-Yl-Propanoyl)Amino]-N-(1-Carbamoyl-2-Hydroxy-Propyl)-16-[(4-Hydroxyphenyl)Methyl]-13-(1H-Indol-3-Ylmethyl)-6,9,12,15,18-Pentaoxo-7-Propan-2-Yl-1,2-Dithia-5,8,11,14,17-Pentazacycloicosane-4-Carboxamide
Lanreotide Acetate is a synthetic cyclic peptide with anti-cancer properties and is used for the treatment of carcinoid syndrome. It binds to somatostatin receptors and inhibits the release of hormones such as gastrin, secretin, vasoactive intestinal peptide, and pancreatic polypeptide. Lanreotide Acetate is used in the treatment of symptoms that are typical for carcinoid syndrome and can also be used in combination with goserelin acetate or triptorelin acetate for patients who do not respond to lanreotide alone. The drug has been shown to be well tolerated in clinical trials and does not show any significant toxicity.
Chemical properties
Technical inquiry about: 3D-CFA98474 Lanreotide acetate
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
